Record Information |
---|
Version | 2.0 |
---|
Created at | 2021-01-06 07:11:53 UTC |
---|
Updated at | 2021-07-15 17:37:45 UTC |
---|
NP-MRD ID | NP0021958 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Amastatin |
---|
Provided By | NPAtlas |
---|
Description | Amastatin belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. Amastatin is found in Streptomyces. Amastatin was first documented in 1978 (PMID: 681249). Based on a literature review very few articles have been published on amastatin (PMID: 18440066) (PMID: 32759368) (PMID: 32609656) (PMID: 31795383) (PMID: 31676291) (PMID: 28701624). |
---|
Structure | [H]OC(=O)C([H])([H])[C@]([H])(N([H])C(=O)[C@@]([H])(N([H])C(=O)[C@@]([H])(N([H])C(=O)[C@@]([H])(O[H])[C@]([H])(N([H])[H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C(=O)O[H] InChI=1S/C21H38N4O8/c1-9(2)7-12(22)17(28)20(31)25-16(11(5)6)19(30)24-15(10(3)4)18(29)23-13(21(32)33)8-14(26)27/h9-13,15-17,28H,7-8,22H2,1-6H3,(H,23,29)(H,24,30)(H,25,31)(H,26,27)(H,32,33)/t12-,13+,15+,16+,17+/m1/s1 |
---|
Synonyms | Value | Source |
---|
Leu[1psi,CHOHCONH]valvalasp | ChEBI | 3-Amino-2-hydroxy-5-methylhexanoyl-L-valyl-L-valyl-L-aspartic acid | MeSH | 3-Amino-2-hydroxy-5-methylhexanoyl-val-val-asp | MeSH |
|
---|
Chemical Formula | C21H38N4O8 |
---|
Average Mass | 474.5550 Da |
---|
Monoisotopic Mass | 474.26896 Da |
---|
IUPAC Name | (2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-3-amino-2-hydroxy-5-methylhexanamido]-3-methylbutanamido]-3-methylbutanamido]butanedioic acid |
---|
Traditional Name | amastatin |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)C[C@@H](N)[C@H](O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C21H38N4O8/c1-9(2)7-12(22)17(28)20(31)25-16(11(5)6)19(30)24-15(10(3)4)18(29)23-13(21(32)33)8-14(26)27/h9-13,15-17,28H,7-8,22H2,1-6H3,(H,23,29)(H,24,30)(H,25,31)(H,26,27)(H,32,33)/t12-,13+,15+,16+,17+/m1/s1 |
---|
InChI Key | QFAADIRHLBXJJS-ZAZJUGBXSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Peptidomimetics |
---|
Sub Class | Hybrid peptides |
---|
Direct Parent | Hybrid peptides |
---|
Alternative Parents | |
---|
Substituents | - Hybrid peptide
- Aspartic acid or derivatives
- Valine or derivatives
- N-acyl-l-alpha-amino acid
- N-acyl-alpha-amino acid
- Acyl-l-homoserine
- Acyl-homoserine
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Beta amino acid or derivatives
- N-substituted-alpha-amino acid
- Alpha-amino acid or derivatives
- Branched fatty acid
- Hydroxy fatty acid
- Dicarboxylic acid or derivatives
- Fatty amide
- Fatty acyl
- Monosaccharide
- N-acyl-amine
- Fatty acid
- Secondary alcohol
- Secondary carboxylic acid amide
- Amino acid or derivatives
- Amino acid
- Carboxamide group
- Carboxylic acid derivative
- Carboxylic acid
- Organopnictogen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organic nitrogen compound
- Organic oxide
- Primary aliphatic amine
- Amine
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Aoyagi T, Tobe H, Kojima F, Hamada M, Takeuchi T, Umezawa H: Amastatin, an inhibitor of aminopeptidase A, produced by actinomycetes. J Antibiot (Tokyo). 1978 Jun;31(6):636-8. doi: 10.7164/antibiotics.31.636. [PubMed:681249 ]
- Tan-No K, Shimoda M, Sugawara M, Nakagawasai O, Niijima F, Watanabe H, Furuta S, Sato T, Satoh S, Arai Y, Kotlinska J, Silberring J, Terenius L, Tadano T: Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception. Neuropeptides. 2008 Jun;42(3):239-44. doi: 10.1016/j.npep.2008.03.003. Epub 2008 Apr 25. [PubMed:18440066 ]
- Kan T, Yoshikawa M, Watanabe M, Miura M, Ito K, Matsuda M, Iwao K, Kobayashi H, Suzuki T, Suzuki T: Sialorphin Potentiates Effects of [Met(5)]Enkephalin without Toxicity by Action other than Peptidase Inhibition. J Pharmacol Exp Ther. 2020 Oct;375(1):104-114. doi: 10.1124/jpet.120.266080. Epub 2020 Aug 5. [PubMed:32759368 ]
- Pascual Alonso I, Rivera Mendez L, Valdes-Tresanco ME, Bounaadja L, Schmitt M, Arrebola Sanchez Y, Alvarez Lajonchere L, Charli JL, Florent I: Biochemical evidences for M1-, M17- and M18-like aminopeptidases in marine invertebrates from Cuban coastline. Z Naturforsch C J Biosci. 2020 Nov 26;75(11-12):397-407. doi: 10.1515/znc-2019-0169. [PubMed:32609656 ]
- Ferreira GM, Kronenberger T, de Almeida EC, Sampaio J, Terra CF, Pinto E, Trossini GHG: Inhibition of Porcine Aminopeptidase M (pAMP) by the Pentapeptide Microginins. Molecules. 2019 Nov 29;24(23). pii: molecules24234369. doi: 10.3390/molecules24234369. [PubMed:31795383 ]
- Bhat SY, Qureshi IA: Mutations of key substrate binding residues of leishmanial peptidase T alter its functional and structural dynamics. Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129465. doi: 10.1016/j.bbagen.2019.129465. Epub 2019 Oct 30. [PubMed:31676291 ]
- Li Q, Jia H, Cao S, Zhang Z, Zheng J, Zhang Y: Biochemical characterization of aminopeptidase N2 from Toxoplasma gondii. J Vet Med Sci. 2017 Aug 18;79(8):1404-1411. doi: 10.1292/jvms.17-0119. Epub 2017 Jul 13. [PubMed:28701624 ]
- Nakamura T, Yamazato M, Ishida A, Ohya Y: Excess of Aminopeptidase A in the Brain Elevates Blood Pressure via the Angiotensin II Type 1 and Bradykinin B2 Receptors without Dipsogenic Effect. Int J Hypertens. 2017;2017:3967595. doi: 10.1155/2017/3967595. Epub 2017 Mar 22. [PubMed:28421141 ]
- Munkhjargal T, Ishizaki T, Guswanto A, Takemae H, Yokoyama N, Igarashi I: Molecular and biochemical characterization of methionine aminopeptidase of Babesia bovis as a potent drug target. Vet Parasitol. 2016 May 15;221:14-23. doi: 10.1016/j.vetpar.2016.02.024. Epub 2016 Feb 27. [PubMed:27084466 ]
- Jin X, Ray R, Ray P: Sulfur mustard-stimulated proteases and their inhibitors in a cultured normal human epidermal keratinocytes model: A potential approach for anti-vesicant drug development. Toxicol Rep. 2016 Mar 15;3:393-400. doi: 10.1016/j.toxrep.2016.03.007. eCollection 2016. [PubMed:28959561 ]
|
---|